4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.

Executive Profile*

Stephen W. Kaldor Ph.D.

AgeTotal Calculated CompensationThis person is connected to 18 board members in 3 different organizations across 10 different industries.

See Board Relationships
54--

Background*

Mr. Stephen W. Kaldor, also known as Steve, PhD, serves as Acting Chief Executive Officer Quanticel Pharmaceuticals, Inc. Mr. Kaldor serves as an Advisor at Thomas, McNerney & Partners and advises on drug discovery. He served as an Advisor of Achaogen, Inc. He is an Associate Editor of the Journal of Combinatorial Chemistry (ACS). He was a Venture Partner at Versant Ventures Inc. He gained over 12 years of research and development, drug discovery and development experience ...

Read Full Background

Corporate Headquarters*

12-10, Nihonbashi 2-chome
Osaka, -- 103-8668

Japan

Phone: 81 3 3278 2111
Fax: 81 3 3278 2000

Board Members Memberships*

Director
2010-Present
Director, Member of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee

Education*

PhD 1989
Harvard University
BA 1984
Columbia University
BS 1984
Columbia University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.